2019年冠状病毒病（COVID-19）疫情期间ST段抬高型心肌梗死的管理：伊朗“247”全国委员会关于直接经皮冠状动脉介入治疗的立场文件
Management of ST-segment-elevation myocardial infarction during the coronavirus disease 2019 (COVID-19) outbreak: Iranian"247" National Committee's position paper on primary percutaneous coronary intervention.
作者信息
Sadeghipour Parham, Talasaz Azita H, Eslami Vahid, Geraiely Babak, Vojdanparast Mohammad, Sedaghat Mojtaba, Moosavi Abouzar Fakhr, Alipour-Parsa Saeed, Aminian Bahram, Firouzi Ata, Ghaffari Samad, Ghasemi Massoud, Saleh Davood Kazemi, Khosravi Alireza, Kojuri Javad, Noohi Feridoun, Pourhosseini Hamid, Salarifar Mojtaba, Salehi Mohamad Reza, Sezavar Hashem, Shabestari Mahmoud, Soleimani Abbas, Tabarsi Payam, Parsa Amir Farhang Zand, Abdi Seifollah
机构信息
Cardiovascular Intervention Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
出版信息
Catheter Cardiovasc Interv. 2021 Feb 15;97(3):E346-E351. doi: 10.1002/ccd.28889. Epub 2020 Apr 22.
Abstract
World Health Organization has designated coronavirus disease 2019 (COVID-19) as a pandemic. During the past several weeks, a considerable burden has been imposed on the Iranian's healthcare system. The present document reviewed the latest evidence and expert opinion regarding the management of ST-segment-elevation myocardial infarction during the outbreak of COVID-19 and outlines a practical algorithm for it.
摘要
世界卫生组织已将2019冠状病毒病（COVID-19）列为大流行病。在过去几周里，伊朗的医疗系统承受了相当大的负担。本文件回顾了关于COVID-19疫情期间ST段抬高型心肌梗死管理的最新证据和专家意见，并概述了针对该疾病的实用算法。
相似文献
1
Management of ST-segment-elevation myocardial infarction during the coronavirus disease 2019 (COVID-19) outbreak: Iranian"247" National Committee's position paper on primary percutaneous coronary intervention.2019年冠状病毒病（COVID-19）疫情期间ST段抬高型心肌梗死的管理：伊朗“247”全国委员会关于直接经皮冠状动脉介入治疗的立场文件
Catheter Cardiovasc Interv. 2021 Feb 15;97(3):E346-E351. doi: 10.1002/ccd.28889. Epub 2020 Apr 22.
2
Management of STEMI during the COVID-19 pandemic: Lessons learned in 2020 to prepare for 2021.COVID-19 大流行期间的 STEMI 管理：2020 年汲取的经验教训，为 2021 年做准备。
Trends Cardiovasc Med. 2021 Apr;31(3):135-140. doi: 10.1016/j.tcm.2020.12.003. Epub 2020 Dec 15.
3
Effects of the COVID-19 Pandemic on the Management of Patients With ST-elevation Myocardial Infarction in a Tertiary Cardiovascular Center.COVID-19 大流行对三级心血管中心 ST 段抬高型心肌梗死患者管理的影响。
Crit Pathw Cardiol. 2021 Mar 1;20(1):53-55. doi: 10.1097/HPC.0000000000000228.
4
In-Hospital Management and Outcomes of Acute Myocardial Infarction Before and During the Coronavirus Disease 2019 Pandemic.新冠肺炎疫情前后急性心肌梗死患者的院内管理和结局。
J Cardiovasc Pharmacol. 2020 Nov;76(5):540-548. doi: 10.1097/FJC.0000000000000909.
5
High Thrombus Burden in Patients With COVID-19 Presenting With ST-Segment Elevation Myocardial Infarction.COVID-19 患者中 ST 段抬高型心肌梗死血栓负荷高。
J Am Coll Cardiol. 2020 Sep 8;76(10):1168-1176. doi: 10.1016/j.jacc.2020.07.022. Epub 2020 Jul 14.
6
ST-Segment-Elevation Myocardial Infarction During COVID-19 Pandemic: Insights From a Regional Public Service Healthcare Hub.COVID-19 大流行期间的 ST 段抬高型心肌梗死：区域性公共服务医疗中心的观察结果。
Circ Cardiovasc Interv. 2020 Aug;13(8):e009413. doi: 10.1161/CIRCINTERVENTIONS.120.009413. Epub 2020 Aug 14.
7
ST-segment elevation in patients with COVID-19: a systematic review.COVID-19 患者的 ST 段抬高：系统评价。
J Thromb Thrombolysis. 2021 Oct;52(3):738-745. doi: 10.1007/s11239-021-02411-9. Epub 2021 Mar 1.
8
Impact of COVID-19 outbreak on regional STEMI care in Germany.COVID-19 疫情对德国区域性 STEMI 治疗的影响。
Clin Res Cardiol. 2020 Dec;109(12):1511-1521. doi: 10.1007/s00392-020-01703-z. Epub 2020 Jul 16.
9
Patient and Provider Risk in Managing ST-Elevation Myocardial Infarction During the COVID-19 Pandemic: A Decision Analysis.在 COVID-19 大流行期间管理 ST 段抬高型心肌梗死的患者和提供者风险：决策分析。
Circ Cardiovasc Interv. 2020 Nov;13(11):e010027. doi: 10.1161/CIRCINTERVENTIONS.120.010027. Epub 2020 Nov 10.
引用本文的文献
1
ST-Segment Elevation Myocardial Infarction (STEMI) Management in the Era of COVID-19: A Systematic and Critical Review of Published Guidance Reports.2019冠状病毒病时代ST段抬高型心肌梗死（STEMI）的管理：对已发表指南报告的系统和批判性综述
Rev Cardiovasc Med. 2023 Feb 6;24(2):54. doi: 10.31083/j.rcm2402054. eCollection 2023 Feb.
2
Effects of the COVID-19 pandemic on the management of ST-Segment elevation myocardial infarction in Indonesia: a cohort study.COVID-19 大流行对印度尼西亚 ST 段抬高型心肌梗死管理的影响：一项队列研究。
F1000Res. 2022 Jun 8;11:629. doi: 10.12688/f1000research.121526.1. eCollection 2022.
3
The Global Effect of the COVID-19 Pandemic on STEMI Care: A Systematic Review and Meta-analysis.《COVID-19 大流行对 STEMI 治疗的全球影响：系统评价和荟萃分析》。
Can J Cardiol. 2021 Sep;37(9):1450-1459. doi: 10.1016/j.cjca.2021.04.003. Epub 2021 Apr 20.
4
Thrombosis Management and Challenges in COVID-19 Patients Presenting with Acute Coronary Syndromes.新冠病毒肺炎合并急性冠脉综合征患者的血栓形成管理与挑战
Heart Views. 2020 Jul-Sep;21(3):195-208. doi: 10.4103/HEARTVIEWS.HEARTVIEWS_143_20. Epub 2020 Oct 13.
5
Thrombosis and Coagulopathy in COVID-19: Current Understanding and Implications for Antithrombotic Treatment in Patients Treated With Percutaneous Coronary Intervention.新型冠状病毒肺炎中的血栓形成与凝血病：当前认识及对接受经皮冠状动脉介入治疗患者抗栓治疗的影响
Front Cardiovasc Med. 2021 Jan 18;7:599334. doi: 10.3389/fcvm.2020.599334. eCollection 2020.
6
The Impact of COVID-19 on In-Hospital Outcomes of ST-Segment Elevation Myocardial Infarction Patients.新型冠状病毒肺炎对ST段抬高型心肌梗死患者院内结局的影响
J Clin Med. 2021 Jan 14;10(2):278. doi: 10.3390/jcm10020278.
7
Management and Outcomes of Patients With STEMI During the COVID-19 Pandemic in China.中国 COVID-19 大流行期间 STEMI 患者的管理和结局。
J Am Coll Cardiol. 2020 Sep 15;76(11):1318-1324. doi: 10.1016/j.jacc.2020.06.039. Epub 2020 Aug 19.
8
Cardiovascular disease management during the coronavirus disease 2019 pandemic.心血管疾病在 2019 冠状病毒病大流行期间的管理。
Int J Med Sci. 2020 May 29;17(10):1340-1344. doi: 10.7150/ijms.46484. eCollection 2020.
9
Effects of the COVID-19 Pandemic on the Management of Patients With ST-elevation Myocardial Infarction in a Tertiary Cardiovascular Center.COVID-19 大流行对三级心血管中心 ST 段抬高型心肌梗死患者管理的影响。
Crit Pathw Cardiol. 2021 Mar 1;20(1):53-55. doi: 10.1097/HPC.0000000000000228.
本文引用的文献
1
The Evolving Pandemic of COVID-19 and Interventional Cardiology.新冠疫情的演变与介入心脏病学
Catheter Cardiovasc Interv. 2020 Sep 1;96(3):507-508. doi: 10.1002/ccd.28894. Epub 2020 Apr 12.
2
Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From the ACC's Interventional Council and SCAI.新型冠状病毒肺炎（COVID-19）大流行期间的心导管实验室考量：来自美国心脏病学会介入委员会和心血管造影和介入学会
J Am Coll Cardiol. 2020 May 12;75(18):2372-2375. doi: 10.1016/j.jacc.2020.03.021. Epub 2020 Mar 19.
3
Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment-Elevation Myocardial Infarction Care in Hong Kong, China.2019年冠状病毒病（COVID-19）疫情对中国香港ST段抬高型心肌梗死治疗的影响
Circ Cardiovasc Qual Outcomes. 2020 Apr;13(4):e006631. doi: 10.1161/CIRCOUTCOMES.120.006631. Epub 2020 Mar 17.
4
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
5
How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan Provincial People's Hospital.如何平衡急性心肌梗死与新型冠状病毒肺炎：四川省人民医院的诊疗方案
Intensive Care Med. 2020 Jun;46(6):1111-1113. doi: 10.1007/s00134-020-05993-9. Epub 2020 Mar 11.
6
Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures.新型冠状病毒肺炎（COVID-19）具有独特的流行病学和临床特征，提示应采取特殊的控制措施。
J Med Virol. 2020 Jun;92(6):568-576. doi: 10.1002/jmv.25748. Epub 2020 Mar 29.
7
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.异常的凝血参数与新型冠状病毒肺炎患者的预后不良有关。
J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13.
8
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
9
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
10
Getting to the Heart of the Matter: A Review of Drug Interactions Between HIV Antiretrovirals and Cardiology Medications.深入探讨药物相互作用：HIV 抗逆转录病毒药物与心脏病学药物的相互作用综述。
Can J Cardiol. 2019 Mar;35(3):326-340. doi: 10.1016/j.cjca.2018.12.020. Epub 2018 Dec 19.
Zotero 插件